Trial Details
TERMINATEDBasic Information
| Clinical ID | c867 |
|---|---|
| Identifier | NCT02895100 |
| Trial Title | Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: PTG-100|DRUG: Placebo |
Participant Information
| Sponsor | Protagonist Therapeutics, Inc. |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-12-16 |
|---|---|
| Primary Completion Date | 2018-03-26 |
| Completion Date | 2018-03-26 |